Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 109.80
-0.10 (-0.09%)
Apr 2, 2026, 5:35 PM CET
Revenue
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Process Solutions Revenue | 3.79B | 3.52B | ||||||||||||
Process Solutions Revenue Growth | 7.46% | -6.87% | ||||||||||||
Life Science Services Revenue | 658.90M | 721.80M | ||||||||||||
Life Science Services Revenue Growth | -8.71% | -8.89% | ||||||||||||
Science & Lab Solutions Revenue | 4.54B | 4.67B | ||||||||||||
Science & Lab Solutions Revenue Growth | -2.91% | -0.73% | ||||||||||||
Life Science Revenue | 8.98B | 8.92B | ||||||||||||
Life Science Revenue Growth | 0.71% | -3.93% | ||||||||||||
Oncology Revenue | 1.93B | 2.01B | ||||||||||||
Oncology Revenue Growth | -4.17% | 10.47% | ||||||||||||
Neurology & Immunology Revenue | 1.66B | 1.69B | ||||||||||||
Neurology & Immunology Revenue Growth | -1.75% | 1.39% | ||||||||||||
Fertility Revenue | 1.46B | 1.53B | ||||||||||||
Fertility Revenue Growth | -4.64% | -1.27% | ||||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue | 3.05B | 2.95B | ||||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue Growth | 3.44% | 5.83% | ||||||||||||
Other Healthcare Revenue | 328.00M | 280.50M | ||||||||||||
Other Healthcare Revenue Growth | 16.93% | 19.16% | ||||||||||||
Healthcare Revenue | 8.61B | 8.45B | ||||||||||||
Healthcare Revenue Growth | 1.81% | 4.98% | ||||||||||||
Display Solutions Revenue | 772.50M | 748.30M | ||||||||||||
Display Solutions Revenue Growth | 3.23% | -2.77% | ||||||||||||
Surface Solutions Revenue | 248.60M | 406.50M | ||||||||||||
Surface Solutions Revenue Growth | -38.84% | -1.07% | ||||||||||||
Semiconductor Solutions Revenue | 2.49B | 2.63B | ||||||||||||
Semiconductor Solutions Revenue Growth | -5.20% | 6.13% | ||||||||||||
Electronics Revenue | 3.51B | 3.79B | ||||||||||||
Electronics Revenue Growth | -7.15% | 3.45% | ||||||||||||
Revenue (Other) | 200.00K | 200.00K | ||||||||||||
Revenue (Total) | 21.10B | 21.16B | ||||||||||||
Revenue (Total) Growth | -0.26% | 0.78% |
Revenue by Geography
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Europe Revenue | 6.42B | 6.17B | ||||||||||||
Europe Revenue Growth | 3.99% | 2.21% | ||||||||||||
North America Revenue | 5.52B | 5.71B | ||||||||||||
North America Revenue Growth | -3.37% | -4.06% | ||||||||||||
Asia Pacific Revenue | 6.94B | 7.02B | ||||||||||||
Asia Pacific Revenue Growth | -1.16% | 1.18% | ||||||||||||
Latin America Revenue | 1.45B | 1.48B | ||||||||||||
Latin America Revenue Growth | -2.02% | 10.91% | ||||||||||||
Middle East & Africa Revenue | 784.60M | 781.20M | ||||||||||||
Middle East & Africa Revenue Growth | 0.43% | 5.98% | ||||||||||||
Revenue (Other) | 300.00K | 300.00K | ||||||||||||
Revenue (Total) | 21.10B | 21.16B | ||||||||||||
Revenue (Total) Growth | -0.26% | 0.78% |
EBITDA
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Life Science EBITDA | 2.59B | 2.59B | ||||||||||||
Life Science EBITDA Growth | -0.16% | -8.17% | ||||||||||||
Healthcare EBITDA | 3.08B | 2.99B | ||||||||||||
Healthcare EBITDA Growth | 2.83% | 17.75% | ||||||||||||
Electronics EBITDA | 832.60M | 969.60M | ||||||||||||
Electronics EBITDA Growth | -14.13% | 6.20% | ||||||||||||
Corporate/Others EBITDA | -388.30M | -481.80M | ||||||||||||
Operating Income (Other) | -2.51B | -2.43B | ||||||||||||
Operating Income (Total) | 3.60B | 3.65B | ||||||||||||
Operating Income (Total) Growth | -1.21% | 1.00% |
Updated Dec 31, 2025. Data Source: Fiscal.ai.